You’re reading free news for HIMS. Sign up free for 3 full 5D deep-dives a month, or start a 14-day Pro trial to unlock the full 5D analysis on more than 3,000 US-listed stocks - no credit card required.

Hims & Hers Health, Inc.· HIMS

🇺🇸 US · MidSP400NYSE

Healthcare Medical - Care Facilities Website

Price: $29.21
Day: 0.00%
Mkt Cap: $6.57B
52W Range: $13.74 – $50.99
Volume: 5.97M
Beta: 2.43

News and Reports

Breaking news, press releases, and analyst updates.

Company news, Oct 22, 2026: Kaplan Fox Reminds Investors of Hims & Hers Health, Inc. (HIMS)…
Analyst rating, Sep 2, 2026: KeyBanc Reiterates Sector Weight Rating on Hims and Hers (HIMS)
Price target, Aug 20, 2026: Hims and Hers (HIMS) PT Lowered to $35 at Barclays

HIMS Latest News

Most recent articles and analysis covering this company.

HIMSNewsfile CorpOct 22, 2026

Kaplan Fox Reminds Investors of Hims & Hers Health, Inc. (HIMS) of the Deadline to Seek Lead Plaintiff Status on November 2, 2026

New York, New York--(Newsfile Corp. - October 22, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Hims & Hers and have suffered losses, you may CLICK HERE to contact us.

newsfilecorp.comRead the article

Also in the news

Defense WorldOct 22, 2026
Hims & Hers Health, Inc. (NYSE:HIMS) Stock Has Consensus Target Price of $32.43
Newsfile CorpOct 21, 2026
HIMS DEADLINE ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class Action - HIMS
PRNewsWireOct 21, 2026
INVESTOR NOTICE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline - HIMS

HIMSNewsfile CorpOct 21, 2026

Kaplan Fox Notifies Investors: Hims & Hers Health, Inc. (HIMS) Faces a Securities Class Action With a November 2, 2026 Deadline

New York, New York--(Newsfile Corp. - October 21, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Hims & Hers and have suffered losses, you may CLICK HERE to contact us.

newsfilecorp.comRead

HIMSPRNewsWireOct 21, 2026

HIMS 12-DAY DEADLINE ALERT: Hims & Hers Health Faces Securities Fraud Class Action, Investors with Losses Encouraged to Contact Hagens Berman

SAN FRANCISCO, Oct. 21, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business misconduct. Hagens Berman, which is actively investigating the alleged claims, encourages HIMS investors who suffered substantial losses to submit your losses now.

prnewswire.comRead

HIMSBusiness WireOct 21, 2026

Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men's Health Launch to Date

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced the launch of new injectable and oral testosterone replacement therapies (TRT) for eligible men. It's the largest expansion of the company's men's health program since first introducing the category last September, giving eligible men more options to treat low testosterone in partnership with licensed providers through Hims. An estimated 20 million men1,2 i.

businesswire.comRead

HIMSGlobeNewsWireOct 21, 2026

Kaplan Fox Alerts Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to an Upcoming Deadline of November 2, 2026 in the Securities Class Action

NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the “Class Period”). CLICK HERE TO JOIN THE CASE If you are an investor in Hims & Hers and have suffered losses, you may CLICK HERE to contact us.

globenewswire.comRead

HIMSNewsfile CorpOct 21, 2026

HIMS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Hims (HIMS) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Hims between August 4, 2025 and July 29, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - October 21, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers Health, Inc. (""Hims" or the "Company") (NYSE: HIMS) and reminds investors of the November 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

newsfilecorp.comRead

HIMSGlobe News WireOct 20, 2026

DEADLINE ALERT for YSS, HIMS, UNCY, and PZZA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, Oct. 20, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

globenewswire.comRead

HIMSNewsfile CorpOct 20, 2026

HIMS DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class Action - HIMS

New York, New York--(Newsfile Corp. - October 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026 lead plaintiff deadline. SO WHAT: If you purchased Hims securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.comRead

HIMSNewsfile CorpOct 20, 2026

Kaplan Fox Encourages Hims & Hers Health, Inc. (HIMS) Investors With Significant Losses to Take Action Before the November 2, 2026 Lead Plaintiff Deadline

New York, New York--(Newsfile Corp. - October 20, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Hims & Hers and have suffered losses, you may CLICK HERE to contact us.

newsfilecorp.comRead

HIMSPRNewsWireOct 20, 2026

Hims & Hers Health (NYSE: HIMS) Facing Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower

SAN FRANCISCO, Oct. 20, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business misconduct. Hagens Berman, which is actively investigating the alleged claims, encourages HIMS investors who suffered substantial losses to submit your losses now.

prnewswire.comRead

Page 1 of 5

News and Reports

Breaking news, press releases, and analyst updates.

Company news, Oct 22, 2026: Kaplan Fox Reminds Investors of Hims & Hers Health, Inc. (HIMS)…

Analyst rating, Sep 2, 2026: KeyBanc Reiterates Sector Weight Rating on Hims and Hers (HIMS)

Price target, Aug 20, 2026: Hims and Hers (HIMS) PT Lowered to $35 at Barclays

Hims & Hers Health, Inc.· HIMS

News and Reports

HIMS Latest News

Search stocks

News and Reports

HIMS Latest News